Induction Healthcare Group PLC Notice of Half-year results (7023H)
28 Novembro 2022 - 4:01AM
UK Regulatory
TIDMINHC
RNS Number : 7023H
Induction Healthcare Group PLC
28 November 2022
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Notice of Half-year results
Investor Presentation
Induction (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, will announce its
half-year results for six months ended 30 September 2022 on Monday
5 December 2022.
Investor Presentation
The Company will be hosting a live online presentation relating
to the half-year results via the Investor Meet Company platform at
4pm (GMT) on Monday 5 December 2022. The presentation is open to
all existing and potential shareholders.
Investors can sign up to Investor Meet Company for free and
register for the presentation here:
https://www.investormeetcompany.com/induction-healthcare-group-plc/register-investor
.
Investors who already follow Induction on the Investor Meet
Company platform will automatically be invited.
Questions can be submitted pre-event via your IMC dashboard or
in real time during the presentation, via the "Ask a Question"
function. Whilst the Company may not be in a position to answer
every question it receives, it will address the most prominent
within the confines of information already disclosed to the market
through regulatory notifications. A recording of the presentation,
a PDF of the slides used, and responses to the Q&A session will
be available on the Investor Meet Company platform afterwards.
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com
James Balmain, Chief Executive Officer
Guy Mitchell, Chief Financial Officer
Singer Capital Markets (Nominated
Adviser and Broker) +44 (0)20 7496 3000
Philip Davies / Kailey Aliyar
Walbrook PR Ltd induction@walbrookpr.com
Paul McManus / Alice Woodings Mob: +44(0)7980 541 893 / +44 (0)7407
804 654
About Induction - www.inductionhealthcare.com
Induction (AIM: INHC) Induction delivers a suite of software
solutions through a single integrated platform that transforms care
delivery. Our system-wide applications help healthcare providers
and administrators to deliver care at any stage remotely as well as
face-to-face - giving the communities they serve greater
flexibility, control and ease of access. Purpose-built for
integration with leading Electronic Medical Record (EMR) platforms,
our products offer immediate stand-alone value that becomes even
greater when integrated with pre-existing systems.
Used at scale by national and regional healthcare systems, as
well non-health government services, our applications are relied
upon by hundreds of thousands of clinicians and millions of
patients across almost every hospital in the British Isles.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORFZMZMFNFGZZZ
(END) Dow Jones Newswires
November 28, 2022 02:01 ET (07:01 GMT)
Induction Healthcare (LSE:INHC)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Induction Healthcare (LSE:INHC)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024